Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints immunology and inflammation research global head

Dr Frank Nestle also becomes North America chief scientific officer

Sanofi Dr Frank NestleSanofi has appointed Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America chief executive officer.

Based out of the French firm's Cambridge, Massachusetts office, Dr Nestle will be responsible for developing Sanofi's early stage immunology and inflammations portfolio and driving its scientific intelligence across multiple therapeutic areas in the US.

He joins Sanofi from King's College London, where he was the Mary Dunhill professor and chair of cutaneous medicine and immunotherapy.

Currently, Dr Nestle serves as lead biomarker for the co-diagnostics, imaging and devices cluster at the Biomedical Research Centre and is the outgoing president of the Federation of Clinical Immunology Societies.

He is a fellow of the Academy of Medical Sciences, a senior investigator emeritus at the National Institute for Health Research and has also served as a non-executive director at Guy's and St Thomas' Foundation Trust Hospital.

12th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

Brexit
Brexit talks threaten supply of medical technologies
As concern grows that the outcome could undermine the regulatory framework...
the_other_side_of_rheumation_arthritis_thumb.jpg
THE OTHER SIDE OF … RHEUMATOID ARTHRITIS
“I harassed my GP enough to get it caught early”...
The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....

Infographics